A study to evaluate the safety and effectiveness of an investigational drug for insomnia (a sleep disorder).

Condition	Treatment or Intervention	Phase
Insomnia		Phase II Phase III

Ages Eligible for Study:  18 Years   -   64 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

• Healthy adults who are between the ages of 18 and 64

Exclusion Criteria:

• Adults who are diagnosed with insomnia

Toll Free Number      1-888-577-8839 

Alabama
      Call for Information, Birmingham,  Alabama,  35213,  United States; Recruiting
Florida
      Call for Information, Miami,  Florida,  33173,  United States; Recruiting
      Call for Information, Pembroke Pines,  Florida,  33026,  United States; Recruiting
Georgia
      Call for Information, Atlanta,  Georgia,  30342,  United States; Recruiting
Kentucky
      Call for Information, Crestview,  Kentucky,  41017,  United States; Recruiting
North Carolina
      Call for Information, Raleigh,  North Carolina,  27612,  United States; Recruiting
Ohio
      Call for Information, Cincinnati,  Ohio,  45246,  United States; Recruiting
      Call for Information, Cincinatti,  Ohio,  45219,  United States; Recruiting
Texas
      Call for Information, Plano,  Texas,  75093,  United States; Recruiting

Study ID Numbers:  2004_092
Record last reviewed:  March 2005
Last Updated:  March 25, 2005
Record first received:  January 21, 2005
ClinicalTrials.gov Identifier:  NCT00102167
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08